St. Jude Children’s Research Hospital is home to 11 scientists named to the 2024 list of Highly Cited Researchers.
Eleven scientists from St. Jude Children’s Research Hospital are among those recognized on the 2024 list of Highly Cited Researchers. The annual list, which was announced today, is compiled by the Web of Science™ together with qualitative analysis performed by experts at the Institute for Scientific Information (ISI)™ at Clarivate.
A Highly Cited Researcher is considered one who has demonstrated significant and broad influence in their fields of investigation. The list represents a small fraction of scientists worldwide who have disproportionately contributed to extending the boundaries of knowledge through innovation and discovery.
Each researcher on the list has authored multiple scientific papers ranking in the top 1% by citations for their fields and publication year over the past decade. Citations refer to how often a published research paper is included as a reference by other investigators in their work, which is a measure of that research paper’s reach and influence.
“Citations form a foundational layer of knowledge that enable the scientific community to build on existing discoveries and advance research and patient care with confidence,” said Kelly Caudle, PharmD, PhD, St. Jude Department of Pharmacy and Pharmaceutical Sciences, and a Highly Cited Researcher.
St. Jude scientists on the 2024 Highly Cited Researchers list represent eight departments:
- Brian Abraham, PhD, Computational Biology (Molecular Biology and Genetics)
- Kelly Caudle, PharmD, PhD, Pharmacy and Pharmaceutical Sciences (Pharmacology and Toxicology)
- Hongbo Chi, PhD, Immunology (Immunology)
- Douglas Green, PhD, Immunology (Immunology, Molecular Biology and Genetics)
- Thirumala-Devi Kanneganti, PhD, Immunology vice-chair (Immunology)
- RK Subbarao Malireddi, PhD, Immunology, Kanneganti Lab (Cross-Field)
- Tanja Mittag, PhD, Structural Biology (Cross-Field)
- Mary Relling, PharmD, Pharmacy and Pharmaceutical Sciences, emeritus (Pharmacology and Toxicology)
- Paul Thomas, PhD, Host-Microbe Interactions and Immunology (Cross-Field)
- Shengdar Tsai, PhD, Hematology (Biology and Biochemistry)
- Peter Vogel, DVM, PhD, Pathology (Immunology)
The 2024 list includes 6,636 researchers from 59 countries and regions, 36.4% of which hail from institutions in the United States.
“I’m honored to have been named to the Highly Cited Researcher list over the past several years,” said Tsai. “It’s a reflection of the broad impact of our work on genome editing technologies and therapies, led by my talented lab members and in collaboration with outstanding scientists worldwide.”
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital is leading the way the world understands, treats and cures childhood cancer, sickle cell disease, and other life-threatening disorders. It is the only National Cancer Institute-designated Comprehensive Cancer Center devoted solely to children. Treatments developed at St. Jude have helped push the overall childhood cancer survival rate from 20% to 80% since the hospital opened more than 60 years ago. St. Jude shares the breakthroughs it makes to help doctors and researchers at local hospitals and cancer centers around the world improve the quality of treatment and care for even more children. To learn more, visit stjude.org, read St. Jude Progress, a digital magazine, and follow St. Jude on social media at @stjuderesearch.